Adeleye Adeshakin
@aadeshakin
Postdoctoral research fellow with an interest in understanding the tumor microenvironment, myeloid suppressive cells, immunometabolism, CAR T cells, CRISPR-CAS9
ID: 703196614
06-10-2013 21:08:34
46 Tweet
38 Followers
61 Following
This study is one of the projects that I’m most delighted to have published as a first author and gave the best of time during my Ph.D training. Thanks to my mentors and co-authors Funmilayo Adeshakin LUKMAN AFOLABI #cancerresearch #MDSC #Lipidmetabolism #FATP2 #ROS pubmed.ncbi.nlm.nih.gov/33524739/
Findings from St. Jude provide a target for improving CAR T-cell therapy. ow.ly/mrUJ50GQozi Science Translational Medicine @GiedreKrenciute Stephen Gottschalk
It was a pleasure meeting with members of The American Association of Immunologists (AAI), including St. Jude’s Dr. Adeleye Adeshakin, Ph.D, and Jeremy Crawford, Ph.D., from Shelby Co. I enjoyed hearing about your research & how immunological advances help prevent and treat infectious diseases. Keep up the great work!
It was indeed an awesome experience at the senator's office to advocate on the need for continous and increased funding to support NIH and ARPA-H for FY2024. This one-year as AAI public policy fellow has been rewarding. Thanks to The American Association of Immunologists (AAI) for this opportunity.
Early career scientists from St. Jude Research and Vanderbilt University had a wonderful coffee chat with Senators Sen. Marsha Blackburn and Senator Bill Hagerty while engaging them on the need for increased funding to support NIH Funding and National Cancer Institute AACR during the Tennessee Tuesday meeting.